Literature DB >> 10647628

Dietary resistant starch and chronic inflammatory bowel diseases.

G Jacobasch1, D Schmiedl, M Kruschewski, K Schmehl.   

Abstract

These studies were performed to test the benefit of resistant starch on ulcerative colitis via prebiotic and butyrate effects. Butyrate, propionate, and acetate are produced in the colon of mammals as a result of microbial fermentation of resistant starch and other dietary fibers. Butyrate plays an important role in the colonic mucosal growth and epithelial proliferation. A reduction in the colonic butyrate level induces chronic mucosal atrophy. Short-chain fatty acid enemas increase mucosal generation, crypt length, and DNA content of the colonocytes. They also ameliorate symptoms of ulcerative colitis in human patients and rats injected with trinitrobenzene sulfonic acid (TNBS). Butyrate, and also to a lesser degree propionate, are substrates for the aerobic energy metabolism, and trophic factors of the colonocytes. Adverse butyrate effects occur in normal and neoplastic colonic cells. In normal cells, butyrate induces proliferation at the crypt base, while inhibiting proliferation at the crypt surface. In neoplastic cells, butyrate inhibits DNA synthesis and arrests cell growth in the G1 phase of the cell cycle. The improvement of the TNBS-induced colonic inflammation occurred earlier in the resistant starch (RS)-fed rats than in the RS-free group. This benefit coincided with activation of colonic epithelial cell proliferation and the subsequent restoration of apoptosis. The noncollagenous basement membrane protein laminin was regenerated initially in the RS-fed group, demonstrating what could be a considered lower damage to the intestinal barrier function. The calculation of intestinal short-chain fatty acid absorption confirmed this conclusion. The uptake of short-chain fatty acids in the colon is strongly inhibited in the RS-free group, but only slightly reduced in the animals fed with RS. Additionally, RS enhanced the growth of intestinal bacteria assumed to promote health. Further studies involving patients suffering from ulcerative colitis are necessary to determine the importance of RS in the therapy of a number of intestinal diseases and the maintenance of health.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10647628     DOI: 10.1007/s003840050212

Source DB:  PubMed          Journal:  Int J Colorectal Dis        ISSN: 0179-1958            Impact factor:   2.571


  21 in total

1.  Etiology of inflammatory bowel syndrome.

Authors:  A Raedler
Journal:  Int J Colorectal Dis       Date:  2001-09       Impact factor: 2.571

2.  Is Pseudobutyrivibrio xylanivorans strain Mz5T suitable as a probiotic? An in vitro study.

Authors:  T Cepeljnik; M Zorec; R Kostanjsek; F V Nekrep; R Marinsek-Logar
Journal:  Folia Microbiol (Praha)       Date:  2003       Impact factor: 2.099

3.  The metabolic activity of fecal microbiota from healthy individuals and patients with inflammatory bowel disease.

Authors:  Marleen H M C van Nuenen; Koen Venema; Janneke C J van der Woude; Ernst J Kuipers
Journal:  Dig Dis Sci       Date:  2004-03       Impact factor: 3.199

4.  Tools for the tract: understanding the functionality of the gastrointestinal tract.

Authors:  Petia Kovatcheva-Datchary; Erwin G Zoetendal; Koen Venema; Willem M de Vos; Hauke Smidt
Journal:  Therap Adv Gastroenterol       Date:  2009-07       Impact factor: 4.409

Review 5.  Potential beneficial effects of butyrate in intestinal and extraintestinal diseases.

Authors:  Roberto Berni Canani; Margherita Di Costanzo; Ludovica Leone; Monica Pedata; Rosaria Meli; Antonio Calignano
Journal:  World J Gastroenterol       Date:  2011-03-28       Impact factor: 5.742

6.  pH and peptide supply can radically alter bacterial populations and short-chain fatty acid ratios within microbial communities from the human colon.

Authors:  Alan W Walker; Sylvia H Duncan; E Carol McWilliam Leitch; Matthew W Child; Harry J Flint
Journal:  Appl Environ Microbiol       Date:  2005-07       Impact factor: 4.792

Review 7.  Intestinal microbiota: The explosive mixture at the origin of inflammatory bowel disease?

Authors:  Roberto Bringiotti; Enzo Ierardi; Rosa Lovero; Giuseppe Losurdo; Alfredo Di Leo; Mariabeatrice Principi
Journal:  World J Gastrointest Pathophysiol       Date:  2014-11-15

8.  Reduced dietary intake of carbohydrates by obese subjects results in decreased concentrations of butyrate and butyrate-producing bacteria in feces.

Authors:  Sylvia H Duncan; Alvaro Belenguer; Grietje Holtrop; Alexandra M Johnstone; Harry J Flint; Gerald E Lobley
Journal:  Appl Environ Microbiol       Date:  2006-12-22       Impact factor: 4.792

9.  Effects of alternative dietary substrates on competition between human colonic bacteria in an anaerobic fermentor system.

Authors:  Sylvia H Duncan; Karen P Scott; Alan G Ramsay; Hermie J M Harmsen; Gjalt W Welling; Colin S Stewart; Harry J Flint
Journal:  Appl Environ Microbiol       Date:  2003-02       Impact factor: 4.792

10.  Innovations in food chemistry and processing to enhance the nutrient profile of the white potato in all forms.

Authors:  Eric A Decker; Mario G Ferruzzi
Journal:  Adv Nutr       Date:  2013-05-01       Impact factor: 8.701

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.